277 related articles for article (PubMed ID: 21727201)
1. Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction.
Nilsson L; Hallén J; Atar D; Jonasson L; Swahn E
Heart; 2012 Jan; 98(1):31-6. PubMed ID: 21727201
[TBL] [Abstract][Full Text] [Related]
2. Soluble TNF receptors are associated with infarct size and ventricular dysfunction in ST-elevation myocardial infarction.
Nilsson L; Szymanowski A; Swahn E; Jonasson L
PLoS One; 2013; 8(2):e55477. PubMed ID: 23405158
[TBL] [Abstract][Full Text] [Related]
3. Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15-42)) on ischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Atar D; Huber K; Rupprecht HJ; Kopecky SL; Schwitter J; Theek C; Brandl K; Henning R; Geudelin B
Cardiology; 2007; 108(2):117-23. PubMed ID: 17019083
[TBL] [Abstract][Full Text] [Related]
4. Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction.
Hallén J; Buser P; Schwitter J; Petzelbauer P; Geudelin B; Fagerland MW; Jaffe AS; Atar D
Am J Cardiol; 2009 Dec; 104(11):1472-7. PubMed ID: 19932777
[TBL] [Abstract][Full Text] [Related]
5. Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Ørn S; Ueland T; Manhenke C; Sandanger Ø; Godang K; Yndestad A; Mollnes TE; Dickstein K; Aukrust P
J Intern Med; 2012 Sep; 272(3):267-76. PubMed ID: 22243053
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and the activity of their tissue inhibitors in patients with ST-elevation myocardial infarction treated with primary angioplasty.
Kuliczkowski W; Urbaniak J; Hallén J; Woźniak M; Poloński L; Mysiak A; Atar D; Zembala M; Serebruany V
Kardiol Pol; 2013; 71(5):453-63. PubMed ID: 23788085
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and their tissue inhibitor after reperfused ST-elevation myocardial infarction treated with doxycycline. Insights from the TIPTOP trial.
Cerisano G; Buonamici P; Gori AM; Valenti R; Sciagrà R; Giusti B; Sereni A; Raspanti S; Colonna P; Gensini GF; Abbate R; Schulz R; Antoniucci D
Int J Cardiol; 2015 Oct; 197():147-53. PubMed ID: 26134371
[TBL] [Abstract][Full Text] [Related]
8. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
Yasuda S; Miyazaki S; Kinoshita H; Nagaya N; Kanda M; Goto Y; Nonogi H
Clin Sci (Lond); 2007 Jan; 112(1):43-9. PubMed ID: 16939410
[TBL] [Abstract][Full Text] [Related]
10. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
[TBL] [Abstract][Full Text] [Related]
11. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.
Atar D; Petzelbauer P; Schwitter J; Huber K; Rensing B; Kasprzak JD; Butter C; Grip L; Hansen PR; Süselbeck T; Clemmensen PM; Marin-Galiano M; Geudelin B; Buser PT;
J Am Coll Cardiol; 2009 Feb; 53(8):720-9. PubMed ID: 19232907
[TBL] [Abstract][Full Text] [Related]
12. The chemokine network in relation to infarct size and left ventricular remodeling following acute myocardial infarction.
Orn S; Breland UM; Mollnes TE; Manhenke C; Dickstein K; Aukrust P; Ueland T
Am J Cardiol; 2009 Nov; 104(9):1179-83. PubMed ID: 19840558
[TBL] [Abstract][Full Text] [Related]
13. Impaired coronary flow and left ventricular dysfunction after mechanical recanalization in acute myocardial infarction: role of neurohumoral activation?
Schäfer U; Kurz T; Jain D; Hartmann F; Dendorfer A; Tölg R; Raasch W; Dominiak P; Katus H; Richardt G
Basic Res Cardiol; 2002 Sep; 97(5):399-408. PubMed ID: 12200640
[TBL] [Abstract][Full Text] [Related]
14. Infarct size and left ventricular function in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study.
Haeck JD; Kuijt WJ; Koch KT; Bilodeau L; Henriques JP; Rohling WJ; Baan J; Vis MM; Nijveldt R; van Geloven N; Groenink M; Piek JJ; Tijssen JG; Krucoff MW; De Winter RJ
Heart; 2010 Feb; 96(3):190-5. PubMed ID: 19858136
[TBL] [Abstract][Full Text] [Related]
15. Relation of cardiac troponin I and microvascular obstruction following ST-elevation myocardial infarction.
Hallén J; Jensen JK; Buser P; Jaffe AS; Atar D
Acute Card Care; 2011 Mar; 13(1):48-51. PubMed ID: 21244230
[TBL] [Abstract][Full Text] [Related]
16. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
[TBL] [Abstract][Full Text] [Related]
17. Influence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty.
Tarantini G; Razzolini R; Cacciavillani L; Bilato C; Sarais C; Corbetti F; Marra MP; Napodano M; Ramondo A; Iliceto S
Am J Cardiol; 2006 Oct; 98(8):1033-40. PubMed ID: 17027566
[TBL] [Abstract][Full Text] [Related]
18. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.
Garcia-Alvarez A; Sitges M; Delgado V; Ortiz J; Vidal B; Poyatos S; de Caralt TM; Heras M; Bosch X; Azqueta M; Pare C; Brugada J
Am J Cardiol; 2009 Oct; 104(7):878-82. PubMed ID: 19766750
[TBL] [Abstract][Full Text] [Related]
19. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction.
Ganame J; Messalli G; Dymarkowski S; Rademakers FE; Desmet W; Van de Werf F; Bogaert J
Eur Heart J; 2009 Jun; 30(12):1440-9. PubMed ID: 19346229
[TBL] [Abstract][Full Text] [Related]
20. Relationship between blood viscosity and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Cecchi E; Liotta AA; Gori AM; Valente S; Giglioli C; Lazzeri C; Sofi F; Gensini GF; Abbate R; Mannini L
Int J Cardiol; 2009 May; 134(2):189-94. PubMed ID: 18495262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
